From June 16–18, CPHI China 2026 (the 24th World Pharmaceutical Ingredients China Expo) will be held at the Shanghai New International Expo Centre (Pudong). As a key exchange platform for the global pharmaceutical industry chain, this year's event will gather leading enterprises and industry experts across pharmaceutical ingredients, finished dosage forms, biotechnology, R&D services, and innovative solutions.
At this year's expo, Matwings Technology will showcase its dialogue-driven protein R&D agent MatwingsVenus™ (Xiaowu™), along with raw material products from its subsidiary, at Booth W9A60. During the event, Li Song, Head of AI+Innovative Drug R&D at Matwings Technology, will deliver an on-site keynote titled "Large Models and Multi-Agent Systems Advancing Innovative Drug R&D and Progress," joining industry partners to explore cutting-edge AI advances in protein design, drug development, and industrial application.
Limited-time free pass offer
Complete visitor registration before 00:00 on June 12, 2026, to receive a free on-site admission pass worth RMB 100!
01 Keynote: Large Models and Multi-Agent Systems Advancing Innovative Drug R&D and Progress
On June 17 at 9:30, Li Song, Head of AI+Innovative Drug R&D at Matwings Technology, will deliver a keynote on the application of large models and multi-agent technologies in drug R&D.
Drawing on Matwings Technology's real-world results in AI+ large-molecule drug development, this talk focuses on deployment and recent technical advances in core scenarios including protein structure prediction, de novo design of novel protein molecules, targeted optimization of protein affinity and stability, and intelligent druggability assessment. The session highlights how multi-agent collaborative systems break down data silos and workflow barriers in large-molecule R&D, enabling intelligent end-to-end iteration across the full R&D pipeline to substantially improve candidate molecule druggability and compress development timelines. The talk also analyzes real-world technical implementation challenges and offers forward-looking insights into AI-driven source innovation and industrialization trends for large-molecule biotherapeutics, delivering cutting-edge strategies and practical guidance for the intelligent upgrading of domestic large-molecule innovative drug R&D.
Keynote Details
📜 Topic: Large Models and Multi-Agent Systems Advancing Innovative Drug R&D and Progress
📆 Time: June 17, 9:30–10:00
📍 Location: E1M13, Shanghai New International Expo Centre
👨💼 Speaker: Li Song | Head of Innovative Drug R&D, Matwings Technology
02 Booth W9A60: Dialogue-Driven Protein R&D Agent MatwingsVenus™ (Xiaowu™)
During CPHI China 2026, Matwings Technology will showcase its dialogue-driven protein R&D agent MatwingsVenus™ (Xiaowu™) and raw material products from its subsidiary at Booth W9A60.
As an agent platform purpose-built for protein R&D scenarios, MatwingsVenus™ enables users to perform deep research, enzyme mining, directed evolution, de novo design, and automated wet lab collaboration through natural language conversation, making complex protein R&D workflows more intuitive, efficient, and executable. On-site visitors can get hands-on experience with MatwingsVenus™, directly experiencing its hard technical capabilities across multiple scenarios including protein engineering, biopharmaceuticals, and synthetic biology — and witnessing first-hand how AI deeply integrates into the full R&D workflow to dramatically accelerate research and development.
Matwings Technology's subsidiary will also showcase products at the booth, including pharmaceutical intermediates, enzyme tools, and affinity purification products developed via MatwingsVenus™-driven directed evolution that surpass traditional products on core performance metrics. These products target biopharmaceutical R&D and production applications, with opportunities for product exchange and partnership discussions with industry upstream and downstream partners.
Booth Information
📍 Booth: W9A60
📅 Dates: June 16–18, 2026
🏢 Venue: Shanghai New International Expo Centre (Pudong)
03 Limited-time free admission — reserve your CPHI on-site pass now
As an exclusive visitor benefit, complete pre-registration before 00:00 on June 12, 2026, to receive a free expo admission pass.
Industry partners planning to attend CPHI China 2026 are encouraged to complete registration in advance and reserve time to visit the Matwings Technology booth and keynote session.
Complete visitor registration before 00:00 on June 12, 2026, to receive a free on-site admission pass worth RMB 100!
